Profile data is unavailable for this security.
About the company
Jiangsu gdk Biotechnology Co Ltd is a biopharmaceutical company engaged in the research, development, production, and sales of human vaccines. The Company’s main product is a tetravalent influenza virus split vaccine, which is mainly used to prevent influenza caused by two influenza A virus strains and two influenza B virus strains. The Company's research products also include a variety of human vaccines for the prevention of epidemic colds, rabies, chickenpox, shingles, and pneumonia. The Company distributes its service within the domestic market.
- Revenue in CNY (TTM)52.65m
- Net income in CNY-113.37m
- Incorporated2008
- Employees451.00
- LocationJiangsu GDK Biotechnology Co LtdNo. 12 Yujin RoadTAIZHOU 225300ChinaCHN
- Phone+86 52 386205860
- Fax+86 52 386200152
- Websitehttp://www.gdkbio.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shaanxi Kanghui Pharmaceutical Co Ltd | 605.28m | -73.67m | 1.59bn | 952.00 | -- | 1.75 | -- | 2.63 | -0.7376 | -0.7376 | 6.06 | 9.12 | 0.292 | 1.86 | 2.74 | 635,795.70 | -4.81 | -0.1562 | -7.31 | -0.1991 | 27.93 | 40.00 | -16.47 | -0.4907 | 0.8304 | -0.9527 | 0.4169 | 95.15 | 36.92 | 12.37 | 58.52 | -- | 66.95 | -- |
| Jiangsu gdk Biotechnology Co Ltd | 52.65m | -113.37m | 1.88bn | 451.00 | -- | 1.43 | -- | 35.80 | -0.9188 | -0.9188 | 0.427 | 10.69 | 0.0321 | 0.4049 | 0.5195 | 116,733.70 | -6.92 | 3.30 | -8.09 | 4.84 | 51.66 | 75.56 | -215.35 | 12.58 | 2.67 | -- | 0.0433 | 32.60 | -57.74 | -- | -270.88 | -- | 54.07 | -- |
| Qinghai Spring Medicinl Rsrcs Tech CoLTD | 251.20m | -287.99m | 1.93bn | 173.00 | -- | 1.69 | -- | 7.67 | -0.4915 | -0.4915 | 0.4298 | 1.94 | 0.1843 | 0.5809 | 4.25 | 1,452,016.00 | -21.01 | -11.25 | -21.83 | -11.55 | 40.40 | 23.44 | -113.97 | -129.81 | 7.06 | -0.9897 | 0.0114 | -- | 33.52 | -8.48 | 6.85 | -- | -20.83 | -- |
| Shanghai Shen Lian Biomedical Corp | 310.36m | -19.73m | 2.21bn | 380.00 | -- | 1.52 | -- | 7.13 | -0.048 | -0.048 | 0.7558 | 3.56 | 0.1944 | 1.16 | 0.9692 | 816,747.00 | -1.48 | 5.39 | -1.58 | 5.84 | 60.66 | 77.45 | -7.62 | 25.48 | 5.14 | -- | 0.0012 | 38.49 | -8.25 | 1.85 | -48.41 | -18.49 | 10.47 | -- |
| Shanghai Serum Bio-Technology Co Ltd | 197.30m | 50.92m | 2.22bn | 321.00 | 43.59 | 1.99 | -- | 11.25 | 0.4706 | 0.4706 | 1.82 | 10.30 | 0.1735 | 1.14 | 3.91 | 614,647.90 | 4.48 | 10.43 | 4.56 | 10.84 | 76.60 | 80.54 | 25.81 | 32.57 | 42.72 | -- | 0.004 | 64.93 | 9.14 | 5.67 | -39.54 | -1.62 | 13.07 | -- |
Data as of Sep 13 2024. Currency figures normalised to Jiangsu GDK Biotechnology Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
6.08%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Rongtong Fund Management Co., Ltd.as of 30 Jun 2024 | 2.47m | 5.76% |
| Harvest Fund Management Co., Ltd.as of 30 Jun 2024 | 38.15k | 0.09% |
| E Fund Management Co., Ltd.as of 30 Jun 2024 | 33.88k | 0.08% |
| GF Fund Management Co., Ltd.as of 30 Jun 2024 | 27.90k | 0.07% |
| Fortune & Royal Asset Management Co., Ltd.as of 30 Jun 2024 | 18.00k | 0.04% |
| Gfund Management Co., Ltd.as of 30 Jun 2024 | 12.54k | 0.03% |
| Bosera Asset Management Co., Ltd.as of 30 Jun 2024 | 4.48k | 0.01% |
| China Merchants Fund Management Co., Ltd.as of 30 Jun 2024 | 2.73k | 0.01% |
| Manulife TEDA Fund Management Co., Ltd.as of 30 Jun 2024 | 1.00k | 0.00% |
| China Universal Asset Management Co., Ltd.as of 30 Jun 2024 | 600.00 | 0.00% |
More ▼
Data from 30 Jun 2024 - 29 Oct 2024Source: FactSet Research Systems Inc.
